(Q48362489)

English

Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice

scientific article published on 25 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

object named as

Annie Andrieux

5

0 references

author name string

Vincent Fournet

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Gaetan de Lavilléon

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Annie Schweitzer

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

Marie-Pascale Martres

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

language of work or name

0 references

publication date

25 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

number of pages

15

1 reference

based on heuristic

inferred from page(s)

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

123

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

982-996

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Cognitive deficits in depression: possible implications for functional neuropathology

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Post-pubertal emergence of alterations in locomotor activity in stop null mice.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Schizophrenia genetics: dysbindin under the microscope

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Current advances and trends in the treatment of depression

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Dopaminergic transmission in STOP null mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The DISC locus in psychiatric illness

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Dysbindin (DTNBP1)--a role in psychotic depression?

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The burden of mental disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The synaptic hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The microtubule cytoskeleton acts as a key downstream effector of neurotransmitter signaling

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Fluoxetine's effects on cognitive performance in patients with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Association of DISC1 with autism and Asperger syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Common risk genes for affective and schizophrenic psychoses

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Mood disorders and allostatic load

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Disruption of two novel genes by a translocation co-segregating with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Therapeutic potential of fluoxetine in neurological disorders

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

An update on the genetics of schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Schizophrenia: genes at last?

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Neurocognitive impairment in drug-free patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Cognitive impairments in the STOP null mouse model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Psychosis pathways converge via D2high dopamine receptors

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Evidence for continuing neuropsychological impairments in depression.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJNC.12027

21 January 2018

Identifiers

10.1111/JNC.12027

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/23013328

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48362489&oldid=2195866106"